D.E. Shaw & Co’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-432,476
| Closed | -$7.2M | – | 3870 |
|
|
2017
Q3 | $7.2M | Buy |
432,476
+27,747
| +7% | +$451K | 0.01% | 1135 |
|
|
2017
Q2 | $7.25M | Buy |
404,729
+63,922
| +19% | +$1.19M | 0.01% | 1080 |
|
|
2017
Q1 | $6.83M | Buy |
340,807
+23,972
| +8% | +$558K | 0.01% | 1084 |
|
|
2016
Q4 | $7.94M | Buy |
316,835
+31,822
| +11% | +$752K | 0.01% | 1080 |
|
|
2016
Q3 | $6.66M | Buy |
285,013
+142,393
| +100% | +$3.35M | 0.01% | 1119 |
|
|
2016
Q2 | $2.85M | Sell |
142,620
-166,731
| -54% | -$3.11M | 0.01% | 1671 |
|
|
2016
Q1 | $5.24M | Sell |
309,351
-173,120
| -36% | -$3.55M | 0.01% | 1236 |
|
|
2015
Q4 | $10.7M | Buy |
482,471
+86,391
| +22% | +$1.8M | 0.02% | 941 |
|
|
2015
Q3 | $6.72M | Sell |
396,080
-77,190
| -16% | -$1.2M | 0.01% | 1197 |
|
|
2015
Q2 | $6.51M | Buy |
473,270
+78,455
| +20% | +$1.04M | 0.01% | 1288 |
|
|
2015
Q1 | $5.41M | Buy |
394,815
+55,923
| +17% | +$645K | 0.01% | 1326 |
|
|
2014
Q4 | $3.58M | Buy |
338,892
+42,851
| +14% | +$507K | ﹤0.01% | 1811 |
|
|
2014
Q3 | $3.7M | Sell |
296,041
-46,408
| -14% | -$647K | ﹤0.01% | 1768 |
|
|
2014
Q2 | $4.68M | Sell |
342,449
-86,585
| -20% | -$1.13M | 0.01% | 1675 |
|
|
2014
Q1 | $5.18M | Sell |
429,034
-53,704
| -11% | -$615K | 0.01% | 1553 |
|
|
2013
Q4 | $5.93M | Buy |
482,738
+169,512
| +54% | +$1.99M | 0.01% | 1540 |
|
|
2013
Q3 | $3.19M | Sell |
313,226
-7,770
| -2% | -$72.6K | 0.01% | 2014 |
|
|
2013
Q2 | $2.88M | Buy |
+320,996
| New | +$3.23M | 0.01% | 1791 |
|
D.E. Shaw & Co's OME Position: Q4 2017 in Review
D.E. Shaw & Co sold out of Omega Protein (OME) in Q4 2017, closing a stake of 432,476 shares — an estimated $7.2M sold.
D.E. Shaw & Co first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $10.7M in Q4 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- D.E. Shaw & Co reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- D.E. Shaw & Co sold 432,476 Omega Protein shares in Q4 2017, an estimated $7.2M.
- D.E. Shaw & Co first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- D.E. Shaw & Co's Omega Protein position peaked at $10.7M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.